Home
Storia in 1 fonti
Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors
Lilly's 13 acquisitions in 2026, worth about $32B, are recycling cash back to at least 50 biotech venture investors.
Raccontata da
endpoints.news
Timeline cronologica
- ·
Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026
Eli Lilly acquires Merida Biosciences for up to $2.875B, gaining MER511 for thyroid eye disease/Graves' disease and MER769 for allergic conditions like asthma.
- ·
Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors
Lilly's 13 acquisitions in 2026, worth about $32B, are recycling cash back to at least 50 biotech venture investors.